Annual Drug Patent Expirations for TRUDHESA
Trudhesa is a drug marketed by Impel Neuropharma and is included in one NDA. There are five patents protecting this drug.
This drug has forty-two patent family members in nine countries.
The generic ingredient in TRUDHESA is dihydroergotamine mesylate. Additional details are available on the dihydroergotamine mesylate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
